LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,118,081 | -16.9% | 135,482 | 0.0% | 0.17% | -12.5% |
Q2 2023 | $9,768,252 | -2.0% | 135,482 | 0.0% | 0.19% | -3.5% |
Q1 2023 | $9,966,056 | +39.8% | 135,482 | +26.9% | 0.20% | +38.2% |
Q4 2022 | $7,131,034 | -34.1% | 106,752 | -15.1% | 0.14% | -37.9% |
Q3 2022 | $10,823,000 | -45.0% | 125,692 | -43.0% | 0.23% | -41.0% |
Q2 2022 | $19,666,000 | -42.4% | 220,422 | -27.4% | 0.39% | -30.2% |
Q1 2022 | $34,132,000 | -27.2% | 303,422 | 0.0% | 0.56% | -19.5% |
Q4 2021 | $46,867,000 | +10.9% | 303,422 | 0.0% | 0.70% | +7.7% |
Q3 2021 | $42,273,000 | -4.2% | 303,422 | -9.7% | 0.65% | -2.1% |
Q2 2021 | $44,106,000 | -28.5% | 336,197 | -16.9% | 0.66% | -33.0% |
Q1 2021 | $61,708,000 | +40.6% | 404,775 | -8.3% | 0.99% | +33.1% |
Q4 2020 | $43,876,000 | +14.2% | 441,190 | +9.4% | 0.74% | -1.3% |
Q3 2020 | $38,428,000 | -3.9% | 403,150 | +12.7% | 0.75% | -6.6% |
Q2 2020 | $39,995,000 | +292.3% | 357,580 | +155.1% | 0.81% | +233.1% |
Q1 2020 | $10,194,000 | -8.0% | 140,175 | +31.9% | 0.24% | +23.5% |
Q4 2019 | $11,086,000 | -5.4% | 106,295 | -9.7% | 0.20% | -8.0% |
Q3 2019 | $11,722,000 | -7.3% | 117,763 | +6.3% | 0.21% | -4.5% |
Q2 2019 | $12,644,000 | -12.9% | 110,763 | -4.1% | 0.22% | -14.6% |
Q1 2019 | $14,514,000 | +15.3% | 115,453 | +24.5% | 0.26% | +3.6% |
Q4 2018 | $12,589,000 | -29.3% | 92,769 | +43.1% | 0.25% | -11.0% |
Q3 2018 | $17,796,000 | +15.7% | 64,832 | -12.7% | 0.28% | +9.7% |
Q2 2018 | $15,379,000 | +23.8% | 74,232 | -1.3% | 0.26% | +21.1% |
Q1 2018 | $12,424,000 | -3.9% | 75,225 | -20.3% | 0.21% | -3.2% |
Q4 2017 | $12,924,000 | -3.8% | 94,385 | -4.3% | 0.22% | -6.0% |
Q3 2017 | $13,435,000 | -4.2% | 98,675 | -14.6% | 0.23% | -4.5% |
Q2 2017 | $14,022,000 | +110.1% | 115,505 | +83.2% | 0.24% | +105.9% |
Q1 2017 | $6,675,000 | +5.0% | 63,065 | +0.8% | 0.12% | 0.0% |
Q4 2016 | $6,356,000 | -8.2% | 62,555 | -7.8% | 0.12% | -4.0% |
Q3 2016 | $6,926,000 | – | 67,860 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |